Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria Last updated: 2023-05-25 18:01
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria Last updated: 2023-02-03 03:36